Brief: Targovax And Agenus Announce Collaboration On Mutant Kras Cancer

Circio Holding ASA

07/03/2022 12:08

March 7 (Reuters) - Targovax ASA  TRVX.OL :
    * TARGOVAX ASA AND AGENUS ANNOUNCE COLLABORATION ON MUTANT
KRAS
CANCER
    * PARTIES HAVE ENTERED INTO A COLLABORATION AGREEMENT TO
DEVELOP
TARGOVAX'S TG MUTANT KRAS CANCER VACCINES IN COMBINATION WITH
AGENUS'S QS-21 STIMULON ADJUVANT TECHNOLOGY
    * AGREEMENT MAY BE EXTENDED INTO AN EXCLUSIVE COMMERCIAL
PARTNERSHIP FOR KRAS VACCINATION IF COMBINATION PROVES EFFECTIVE
IN EXPLORATORY CLINICAL STUDIES

Source text for Eikon:  ID:nObiybRZma 
Further company coverage:  TRVX.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))